These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26463637)

  • 1. Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania(L.) amazonensis amastigotes.
    de Almeida L; Alves KF; Maciel-Rezende CM; Jesus Lde O; Pires FR; Junior CV; Izidoro MA; Júdice WA; dos Santos MH; Marques MJ
    Biomed Pharmacother; 2015 Oct; 75():93-9. PubMed ID: 26463637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones.
    Maciel-Rezende CM; de Almeida L; Costa ÉD; Pires FR; Alves KF; Viegas C; Dias DF; Doriguetto AC; Marques MJ; dos Santos MH
    Bioorg Med Chem; 2013 Jun; 21(11):3114-9. PubMed ID: 23623672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor.
    Assis DM; Gontijo VS; de Oliveira Pereira I; Santos JA; Camps I; Nagem TJ; Ellena J; Izidoro MA; dos Santos Tersariol IL; de Barros NM; Doriguetto AC; dos Santos MH; Juliano MA
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):661-70. PubMed ID: 22468751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stachytarpheta cayennensis extract inhibits promastigote and amastigote growth in Leishmania amazonensis via parasite arginase inhibition.
    Maquiaveli CDC; Oliveira E Sá AM; Vieira PC; da Silva ER
    J Ethnopharmacol; 2016 Nov; 192():108-113. PubMed ID: 27432217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of quinoline derivatives as potential cysteine protease inhibitors.
    Andrade MM; Martins LC; Marques GV; Silva CA; Faria G; Caldas S; Dos Santos JS; Leclercq SY; Maltarollo VG; Ferreira RS; Oliveira RB
    Future Med Chem; 2020 Apr; 12(7):571-581. PubMed ID: 32116030
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
    Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
    Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
    Gontijo VS; Espuri PF; Alves RB; de Camargos LF; Santos FV; de Souza Judice WA; Marques MJ; Freitas RP
    Eur J Med Chem; 2015 Aug; 101():24-33. PubMed ID: 26112378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmanicidal activity of lipophilic extracts of some Hypericum species.
    Dagnino AP; Barros FM; Ccana-Ccapatinta GV; Prophiro JS; Poser GL; Romão PR
    Phytomedicine; 2015 Jan; 22(1):71-6. PubMed ID: 25636874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.
    Chenna BC; Li L; Mellott DM; Zhai X; Siqueira-Neto JL; Calvet Alvarez C; Bernatchez JA; Desormeaux E; Alvarez Hernandez E; Gomez J; McKerrow JH; Cruz-Reyes J; Meek TD
    J Med Chem; 2020 Mar; 63(6):3298-3316. PubMed ID: 32125159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
    Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syzygium cumini (L.) Skeels essential oil and its major constituent α-pinene exhibit anti-Leishmania activity through immunomodulation in vitro.
    Rodrigues KA; Amorim LV; Dias CN; Moraes DF; Carneiro SM; Carvalho FA
    J Ethnopharmacol; 2015 Feb; 160():32-40. PubMed ID: 25460590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
    Soares DC; Andrade AL; Delorenzi JC; Silva JR; Freire-de-Lima L; Falcão CA; Pinto AC; Rossi-Bergmann B; Saraiva EM
    Parasitol Int; 2010 Jun; 59(2):173-7. PubMed ID: 20096374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
    da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
    Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
    Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
    Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
    Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
    Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal compounds for the treatment of parasitic diseases.
    Fricker SP; Mosi RM; Cameron BR; Baird I; Zhu Y; Anastassov V; Cox J; Doyle PS; Hansell E; Lau G; Langille J; Olsen M; Qin L; Skerlj R; Wong RS; Santucci Z; McKerrow JH
    J Inorg Biochem; 2008 Oct; 102(10):1839-45. PubMed ID: 18684510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
    Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
    Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.